Lede Three recent developments—the launch of a low-cost immunotherapy cancer drug in India, sustained oncology-driven revenue momentum at a global pharmaceutical major, and a high-value R&D collabo... Read News
Published date : January 27, 2026
Industry Insights from Next Move Strategy Consulting Researchers from the Korea Advanced Institute of Science and Technology (KAIST) have announced a significant leap in personalized cancer therapy... Read News
Published date : January 1, 2026
Lede - Three recent research threads - a deeper look at how propofol causes unconsciousness, promising results for nebulized dexmedetomidine in pediatric GI endoscopy, and early-stage work repurposing... Read News
Published date : October 31, 2025
The global cancer therapeutics landscape is undergoing a significant transformation, with new drug approvals, region-specific advancements, and strategic partnerships defining the path forward. From h... Read News
Published date : October 31, 2025
Industry Insights from Next Move Strategy Consulting In a bold assertion of maritime interdiction efforts, the United States has launched another strike operation on a suspected drug-transporting v... Read News
Published date : October 22, 2025
The global Brain Health Supplements Market is undergoing a major transformation in 2025, driven by a shift from generic nootropics to evidence-based, scientifically validated formulations. Industry pl... Read News
Published date : October 13, 2025
Industry Insights from Next Move Strategy Consulting The U.S. Food and Drug Administration on Friday approved updates to the labeling of Johnson & Johnson and Legend Biotech’s blood cancer therapy... Read News
Published date : October 12, 2025
The Brain Health Supplements Market enters a dynamic phase in 2025, fueled by scientific advancements in nootropics and nutrient-focused formulations. As cognitive demands rise in professional and ath... Read News
Published date : October 8, 2025
Industry Insights from Next Move Strategy Consulting In an era of rising antimicrobial resistance, Lumos Diagnostics (ASX:LDX) has unveiled compelling real-world evidence showcasing its FebriDx poi... Read News
Published date : September 23, 2025
Industry Insights from Next Move Strategy Consulting Amid rising prevalence of metabolic syndrome and its ties to cognitive impairments, a recent mouse study unveils a critical neurological pathway... Read News
Published date : September 23, 2025